BUY AMAT

0.787401574 shares at $439.84 on 2026-05-15

Reasoning

Thesis #33 upgraded to medium confidence on blowout Q2 earnings ($7.91B revenue, beat by $260M) and raised 2026 equipment growth guidance to 30%+. Q3 guidance $8.95B far exceeds consensus $8.09B. Multiple analyst PT raises validate earnings quality. Trump-Xi summit concluded without adverse semiconductor export language — Rule #11 deferral CLEARED. AMAT's 1.7% resilience today despite broad market selloff (SPY -0.90%, QQQ -1.04%) signals institutional support. Formation-mode sizing ($350) aligns with Rule #1 and limits downside given typical post-earnings volatility (avg -3.6% on prior 5 releases). Conviction remains medium due to valuation proximity to 52-week highs and binary earnings risk, but catalyst window is now open.

Thesis

AMAT semiconductor-equipment long — structural WFE-demand case REINFORCED Oct 8 by the fresh TSMC capex headline: TSMC (the primary driver of leading-edge WFE orders) reaffirmed a 2026 capex envelope of $60-64B with revenue growth above 40%, driven by the 2nm ramp and surging CoWoS advanced-packaging demand, management citing AI demand robust through 2030. That long-cycle foundry capex underpins AMAT's order book — a durable fundamental counter to the OpenAI-revenue-reset AI-capex-scrutiny selloff hitting ORCL/NVDA/MSFT today. Equipment names are less directly exposed to the OpenAI single-counterparty demand reset than the capex-debt-financed cloud builders (ORCL), since TSMC's broad-based multi-customer capex drives AMAT's demand. Valuation regime stays hostile (30Y Treasury nearing 6%, fresh long-end spike de-rating high-multiple growth), so this remains hold-the-core-via-trail with NO adds per Rule #14 (active). (long, medium confidence)

Outcome

7-day: +1.90% · 30-day: +64.40%

Cited evidence

News

Macro